This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to The Market Chronicle to get the Daily Monster Market Commentary and join the 2,892 subscribers getting it for FREE!
September 9, 2021
STOCKS – UPS, CSX, MRK, CAT
MACRO – SPY, QQQ, DJT
- The Fed May Be Forced To Taper Soon
- RTM Exclusive – Micron’s Stock Is About To See A Whole Lot Of Turbulence
- RTM- Next Live Session Friday 9.10.21 @ 1PM ET
- RTM- Similiar Patterns
- RTM Exclusive: The ARKK ETF May Sink Even Lower
- RTM – Earnings Downgrades Should Be Next
- RTM Exclusive: Has Uber Finally Bottomed?
- RTM Tactical Update: The Equity Market Continues Down The 2018 Rabbit Hole
The S&P 500 fell for the fourth day in a row and is down 93 basis points for the week, which is really nothing. The index has been overextended, so now we are just reverting to the other end of the bands. I still think we can fall to the lower Bollinger band around 4,400. There is, from a gamma perspective, some pretty solid support around 4,440, if that level breaks, it could get interesting, with no real gamma support again until 4,250. I noted this in a write-up I did for Spotgamma this week.
The level on the RSI to watch is at 42. That has been an extremely strong level of support for the RSI. To be honest, you don’t see a level on the RSI acting as support very often. The RSI is great for helping to determine the long-term trends, but this case happens to be strange. So I would think if 42 breaks, it is likely to be meaningful.
The interesting thing about the Qs is that there is now a bearish divergence on the RSI, with the RSI making a lower high as the ETF is making a higher high. From what I can see, it doesn’t happen too often, February 2020, August 2018, May 2017, and July 2014 were the last time it happened. The July 2014 decline lead to a 10% decline in the ETF, while May 2017 lead to a 6% decline, August 2018 led to a 20% decline; I don’t have to tell you what happened in March 2020. So at the very least, this is something one must watch really closely.
Subscribe to the The Market Chronicle to get it Daily and join the 2,892 subscribers getting it for FREE!
Dow Jones Transport (DJT)
The transports look really bad, with the Dow Jones Transport average down 1% and back to the low end of its trading range. Some of the stocks suggests that the average has further to fall, and that is really concerning.
UPS is one such stock and it looks really weak. It is on the cusp of breaking support and on its way back to filling the gap at $178.
CSX could be working on forming a double top pattern. It will need to fall below $31 for confirmation.
Merck has been hit really hard the past few days since Morgan Stanley downgraded the stock to equal-weight from overweight, and amid concerns over drug pricing. The drug pricing thing has been an issue for years already and nothing ever gets done, maybe this time it does, I don’t know. But the stock fell below the uptrend and filled the gap around $74. If the stock breaks $73, my thoughts of it rising to $81 may be toast.
Caterpillar is resting on support at $180, and I don’t think it will be too much longer until that support breaks and the stock heads to $180.
Have a good one
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and, unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.